HHS cancels Moderna contract despite ongoing bird flu threat

The latest stories trending on MedCity News.

Editor's Pick

Top Story Bird Flu Threat Still Looms, But HHS Just Canceled a Moderna Contract That Could Prepare for It Messenger RNA technology offers a faster way to develop vaccines to address or prepare for pandemics, and Moderna's vaccine candidate for avian influenza is on track for Phase 3 testing. But the Department of Health and Human Services has canceled a $590 million contract to support Moderna's pivotal trial. Sponsored Webinar: Using RWD to Improve Clinical Trial Recruitment, Endpoints, and Inform Market Access Strategies Presented by PurpleLab Gaining greater insight into the patient journey from diagnosis through treatment is a priority for drug developers as they seek to produce more effective drugs. The panel will explore how to leverage real world data (RWD) to eliminate blind spots in the patient journey — informing every phase of a drug's lifecycle, from clinical development to market access. Sign up to watch now

Featured News

Precision Pfizer Drug Leads to 'Unprecedented' Survival in Colorectal Cancer, Data at ASCO Show Pfizer drug Braftovi achieved statistically significant and clinically meaningful improvement in overall survival for colorectal cancer patients in a Phase 3 clinical trial. The results will be presented Friday during the annual meeting of the American Society of Clinical Oncology. Priority Health Teams Up with Virta Health for Diabetes, Weight Loss Support Priority Health has partnered with Virta Health to offer a suite of diabetes and weight management solutions to its employer clients. Why Is Medtronic Spinning Off Its Diabetes Business? Medtronic's move to turn its diabetes division into a separate company allows it to step away from a lower-profit, consumer-oriented segment of its business, while also giving the diabetes unit more room to focus and compete in its own crowded market. Latest Patent News In Women's Health The women's health market offers enormous potential for investment and innovation. While challenges related to systemic inequalities remain, progress in venture capital funding is encouraging. Likewise, the overall increase in patent filings related to breast cancer, endometriosis, and other conditions appears to reflect a growing interest in women's health. Rebuttal: Medical Device Right to Repair is the Wrong Approach Allowing hospitals to repair the equipment they depend upon daily is not a step backward, but a reaffirmation of trust in the skilled and deeply committed professionals who already maintain the integrity of our healthcare systems.

Video   What Will It Take to Fix Prior Authorization? Nowadays, there is much discussion about innovation and the role technology can play to improve the healthcare industry — but one expert is frustrated by the lack of movement in the prior authorization space. Jesse Ehrenfeld, immediate past president of the American Medical Association, pointed this out at MedCity News' INVEST conference in Chicago. The AMA has dedicated a lot of time and effort to working with payers and providers to establish a set of consensus guidelines for what the prior authorization process should look like — but payers aren't really coming to the table to make the necessary changes, Ehrenfeld said. "Got thrown out the window, completely ignored by the payer community," he stated.

Sponsored The Best Options for Diagnostic Imaging Covered by Medicare Presented by Envision Radiology Health care professionals can refer patients to the best options for diagnostic imaging covered by Medicare to give more people the medical assistance they need without extra financial stress. Learn More

Resources

MedCity Pivot Podcast: Precision Medicine with the CEO of Helix In this episode of the MedCity Pivot Podcast, editor-in-chief Arundhati Parmar, speaks with Helix CEO James Lu about his company and how far precision medicine has come. Watch Now

MedCity News • PO Box 901 • New York, NY unsubscribe